Immunomodulatory effects of nanomaterials : assessment and analysis / edited by Mahmoud Elsabahy, School of Biotechnology, Badr University in Cairo, Badr City, Cairo, Egypt
Front Cover -- Immunomodulatory Effects of Nanomaterials -- Copyright Page -- Contents -- List of contributors -- About the editor -- Preface -- Acknowledgments -- Introduction -- 1 Nanomaterials: classification, composition, and recent advances in synthesis -- 1.1 Introduction to nanotechnology -- 1.2 Terminology of nanotechnology -- 1.3 Unique properties of nanomaterials -- 1.4 Classification of nanomaterials -- 1.4.1 Polymeric nanoparticles -- 1.4.2 Nanoemulsions -- 1.4.3 Inorganic nanoparticles -- 1.4.4 Carbonaceous nanomaterials -- 1.5 Nanomaterial synthesis -- 1.6 Characterization of nanomaterials -- 1.6.1 Stability and surface chemistry -- 1.6.2 Particle size measurement and polydispersity -- 1.6.3 Electron microscopy and imaging -- 1.6.4 Ultraviolet-visible spectroscopy -- 1.7 Concluding remarks and future avenue -- References -- 2 Applications of nanoengineered therapeutics and vaccines: special emphasis on COVID-19* -- 2.1 Coronavirus disease-2019 -- 2.2 Morphological structure and genome -- 2.3 Clinical presentation, radiological features, and laboratory investigations -- 2.4 Therapeutic attempts -- 2.5 Antiviral therapy -- 2.6 Lopinavir/ritonavir and Arbidol -- 2.7 Immune therapy -- 2.7.1 Convalescent plasma therapy -- 2.8 Tocilizumab -- 2.9 Bamlanivimab (LY3819253 or LY-CoV555) and Etesevimab (LY3832479 or LY-CoV016) -- 2.10 Casirivimab (previously REGN10933) and imdevimab (previously REGN10987) -- 2.11 JAK inhibitors -- 2.12 Baricitinib -- 2.13 Ruxolitinib -- 2.14 Jakotinib -- 2.15 Vaccines -- 2.16 Nanoengineered therapeutics and vaccines in development for management of COVID-19 -- 2.16.1 Nanoengineered therapeutics -- 2.16.2 Nanoengineered vaccines -- 2.17 Current status and perspectives -- Acknowledgment -- References -- 3 Nanomaterials and immune system* -- 3.1 Introduction -- 3.2 The immune system..
Immunomodulatory Effects of Nanomaterials: Assessment and Analysis provides an overview of the modulatory impact of nanomaterials on the immune system, as well as evaluative and analytical methods for assessing effects. Sections cover a range of common nanomaterials for biomedical use and how different properties can elicit varied responses from the immune system. The immunomodulatory effects of these materials are then discussed, with coverage on adverse and/or toxic effects on the immune system, as well as desired modulatory effects to improve efficacy of applied therapeutics. Readers will also learn about the best evaluation methods for immunomodulatory effects of nanomaterials and associated risks. This book is a useful reference for academics and researchers with an interest in immunology, but it is also idea for those working in the fields of materials science, biomedical engineering, pharmaceutical science, immunology and toxicology..
Medienart: |
Buch |
---|
Erscheinungsjahr: |
[2022] © 2022 |
---|---|
Erschienen: |
Cambridge, MA Kidlington, UK: Woodhead Publishing WP, an imprint of Elsevier ; 2022 © 2022 |
Weitere Ausgaben: |
Erscheint auch als Online-Ausgabe: Immunomodulatory Effects of Nanomaterials |
---|
Reihe: |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Elsabahy, Mahmoud [HerausgeberIn] |
---|
ISBN: |
---|
BKL: | |
---|---|
Themen: |
Anmerkungen: |
Literaturangaben |
---|
Umfang: |
xviii, 175 Seiten ; Illustrationen, Diagramme |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1810012538 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1810012538 | ||
003 | DE-627 | ||
005 | 20230405131002.0 | ||
007 | tu | ||
008 | 220713s2022 xxk||||| 00| ||eng c | ||
020 | |a 9780323906043 |c print |9 978-0-323-90604-3 | ||
020 | |a 9780323908245 |c online |9 978-0-323-90824-5 | ||
035 | |a (DE-627)1810012538 | ||
035 | |a (DE-599)KXP1810012538 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XA-GB |c XD-US | ||
084 | |a 44.45 |2 bkl | ||
245 | 1 | 0 | |a Immunomodulatory effects of nanomaterials |b assessment and analysis |c edited by Mahmoud Elsabahy, School of Biotechnology, Badr University in Cairo, Badr City, Cairo, Egypt |
264 | 1 | |a Cambridge, MA |a Kidlington, UK |b Woodhead Publishing WP, an imprint of Elsevier |c [2022] | |
264 | 4 | |c © 2022 | |
300 | |a xviii, 175 Seiten |b Illustrationen, Diagramme | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
490 | 0 | |a Woodhead Publishing series in biomaterials | |
500 | |a Literaturangaben | ||
520 | |a Front Cover -- Immunomodulatory Effects of Nanomaterials -- Copyright Page -- Contents -- List of contributors -- About the editor -- Preface -- Acknowledgments -- Introduction -- 1 Nanomaterials: classification, composition, and recent advances in synthesis -- 1.1 Introduction to nanotechnology -- 1.2 Terminology of nanotechnology -- 1.3 Unique properties of nanomaterials -- 1.4 Classification of nanomaterials -- 1.4.1 Polymeric nanoparticles -- 1.4.2 Nanoemulsions -- 1.4.3 Inorganic nanoparticles -- 1.4.4 Carbonaceous nanomaterials -- 1.5 Nanomaterial synthesis -- 1.6 Characterization of nanomaterials -- 1.6.1 Stability and surface chemistry -- 1.6.2 Particle size measurement and polydispersity -- 1.6.3 Electron microscopy and imaging -- 1.6.4 Ultraviolet-visible spectroscopy -- 1.7 Concluding remarks and future avenue -- References -- 2 Applications of nanoengineered therapeutics and vaccines: special emphasis on COVID-19* -- 2.1 Coronavirus disease-2019 -- 2.2 Morphological structure and genome -- 2.3 Clinical presentation, radiological features, and laboratory investigations -- 2.4 Therapeutic attempts -- 2.5 Antiviral therapy -- 2.6 Lopinavir/ritonavir and Arbidol -- 2.7 Immune therapy -- 2.7.1 Convalescent plasma therapy -- 2.8 Tocilizumab -- 2.9 Bamlanivimab (LY3819253 or LY-CoV555) and Etesevimab (LY3832479 or LY-CoV016) -- 2.10 Casirivimab (previously REGN10933) and imdevimab (previously REGN10987) -- 2.11 JAK inhibitors -- 2.12 Baricitinib -- 2.13 Ruxolitinib -- 2.14 Jakotinib -- 2.15 Vaccines -- 2.16 Nanoengineered therapeutics and vaccines in development for management of COVID-19 -- 2.16.1 Nanoengineered therapeutics -- 2.16.2 Nanoengineered vaccines -- 2.17 Current status and perspectives -- Acknowledgment -- References -- 3 Nanomaterials and immune system* -- 3.1 Introduction -- 3.2 The immune system. | ||
520 | |a Immunomodulatory Effects of Nanomaterials: Assessment and Analysis provides an overview of the modulatory impact of nanomaterials on the immune system, as well as evaluative and analytical methods for assessing effects. Sections cover a range of common nanomaterials for biomedical use and how different properties can elicit varied responses from the immune system. The immunomodulatory effects of these materials are then discussed, with coverage on adverse and/or toxic effects on the immune system, as well as desired modulatory effects to improve efficacy of applied therapeutics. Readers will also learn about the best evaluation methods for immunomodulatory effects of nanomaterials and associated risks. This book is a useful reference for academics and researchers with an interest in immunology, but it is also idea for those working in the fields of materials science, biomedical engineering, pharmaceutical science, immunology and toxicology. | ||
655 | 7 | |a Aufsatzsammlung |0 (DE-588)4143413-4 |0 (DE-627)105605727 |0 (DE-576)209726091 |2 gnd-content | |
689 | 0 | 0 | |D s |0 (DE-588)4342626-8 |0 (DE-627)153672439 |0 (DE-576)211436038 |a Nanostrukturiertes Material |2 gnd |
689 | 0 | 1 | |D s |0 (DE-588)4315157-7 |0 (DE-627)126508380 |0 (DE-576)211170496 |a Immunmodulation |2 gnd |
689 | 0 | |5 (DE-627) | |
700 | 1 | |a Elsabahy, Mahmoud |e herausgeberin |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 9780323908245 |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Elsabahy, Mahmoud |t Immunomodulatory Effects of Nanomaterials |d San Diego : Elsevier Science & Technology, 2022 |h 1 online resource (195 pages) |w (DE-627)180776379X |z 9780323908245 |
912 | |a GBV_ILN_20 | ||
912 | |a ISIL_DE-84 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
936 | b | k | |a 44.45 |j Immunologie |0 (DE-627)106409689 |
951 | |a BO | ||
980 | |2 20 |1 01 |x 0084 |b 4164729600 |c 00 |f MAG |d 2969-8574 |e --%%-- |j --%%-- |y k |z 22-11-22 | ||
984 | |2 20 |1 01 |x 0084 |a 84$103645126 |